Effectiveness and cost-effectiveness of antibiotic treatments for community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB).

医学 阿奇霉素 抗生素 肺炎 支气管炎 慢性支气管炎 重症监护医学 社区获得性肺炎 呼吸道感染 药方 内科学 呼吸系统 生物 微生物学 药理学
作者
Frédéric Lavoie,Lucie Blais,Anne‐Marie Castilloux,Alissa Scalera,Jacques LeLorier
出处
期刊:PubMed [National Institutes of Health]
卷期号:12 (2): e212-7 被引量:5
链接
标识
摘要

BACKGROUND: The antibacterial activity, tolerability profile and duration of treatment associated with antibiotics are important therapy attributes when considering treating patients for lower respiratory tract infections (LRTIs), such as community acquired pneumonia (CAP) and acute exacerbations of chronic bronchitis (AECB). OBJECTIVES: To investigate the effectiveness and cost-effectiveness of oral antibiotics used in the treatment of LRTIs. METHODS: A cohort of inhaled corticosteroids users who were diagnosed with a LRTI and dispensed a prescription for one of the antibiotics under study on the same day as the diagnosis was selected from the administrative health databases of the Régie de l'assurance maladie du Québec (RAMQ). The risks of treatment failure were estimated using a logistic regression analysis. Treatment failure was defined as another prescription for any antibiotic, an emergency room visit or hospitalization for LRTIs, or death, in the 20 days following the dispensation of the first antibiotic prescribed. A cost-minimization analysis was performed in which only the drug costs related to the first antibiotic filled were considered. RESULTS: A total of 3,610 episodes of LRTIs were studied. There were no significant differences between antibiotics in terms of their respective adjusted odds ratios for rates of failure. However, the lower cost associated with azithromycin was significantly different from the costs associated with any other antibiotic (p<0.0001). CONCLUSION: Clinical effectiveness appears to be similar amongst second line antibiotics that are commonly used in the treatment of LRTIs in the community. Using a cost-minimization analysis, azithromycin appears to be the most cost-effective antibiotic treatment in this setting.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
所所的应助被我明天要吃蛋挞采纳,获得10
1秒前
1秒前
白云完成签到,获得积分10
2秒前
李依伊完成签到 ,获得积分10
3秒前
淡淡青枫完成签到,获得积分10
4秒前
笑点低的新烟完成签到 ,获得积分10
4秒前
5秒前
6秒前
yang111发布了新的文献求助10
6秒前
宇宙小仙女完成签到,获得积分10
7秒前
8秒前
lile完成签到,获得积分10
8秒前
追寻向雁完成签到,获得积分20
8秒前
8秒前
爆米花的应助被JACS采纳,获得10
9秒前
hmm完成签到,获得积分10
9秒前
秋风的应助被李123采纳,获得20
10秒前
LL完成签到 ,获得积分10
10秒前
W7完成签到 ,获得积分10
10秒前
syvshc的应助被VV采纳,获得10
11秒前
12秒前
12秒前
12秒前
13秒前
暖枝完成签到,获得积分10
14秒前
14秒前
苹果画板完成签到,获得积分10
14秒前
14秒前
15秒前
追寻向雁发布了新的文献求助10
15秒前
LYQ完成签到,获得积分10
15秒前
万能图书馆的应助被张正采纳,获得10
15秒前
泡泡完成签到,获得积分10
16秒前
于向沉完成签到 ,获得积分10
16秒前
16秒前
nannan626发布了新的文献求助10
17秒前
鉨汏闫发布了新的文献求助10
18秒前
Mia发布了新的文献求助20
18秒前
maomao发布了新的文献求助10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8168144
求助须知:如何正确求助?哪些是违规求助? 9561199
关于积分的说明 21759542
捐赠科研通 7759434
什么是DOI,文献DOI怎么找? 3429948
关于科研通互助平台的介绍 2553742
邀请新用户注册赠送积分活动 2474463